Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 275

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

Open access
Giri, Veda N., Knudsen, Karen E., Kelly, William K., Cheng, Heather H., Cooney, Kathleen A., Cookson, Michael S., Dahut, William, Weissman, Scott, Soule, Howard R., Petrylak, Daniel P., Dicker, Adam P., AlDubayan, Saud H., Toland, Amanda E., Pritchard, Colin C., Pettaway, Curtis A., Daly, Mary B., Mohler, James L., Parsons, J. Kellogg, Carroll, Peter R., Pilarski, Robert, Blanco, Amie, Woodson, Ashley, Rahm, Alanna, Taplin, Mary-Ellen, Polascik, Thomas J., Helfand, Brian T., Hyatt, Colette, Morgans, Alicia K., Feng, Felix, Mullane, Michael, Powers, Jacqueline, Concepcion, Raoul, Lin, Daniel W., Wender, Richard, Mark, James Ryan, Costello, Anthony, Burnett, Arthur L., Sartor, Oliver, Isaacs, William B., Xu, Jianfeng, Weitzel, Jeffrey, Andriole, Gerald L., Beltran, Himisha, Briganti, Alberto, Byrne, Lindsey, Calvaresi, Anne, Chandrasekar, Thenappan, Chen, David Y. T., Den, Robert B., Dobi, Albert, Crawford, E. David, Eastham, James, Eggener, Scott, Freedman, Matthew L., Garnick, Marc, Gomella, Patrick T., Handley, Nathan, Hurwitz, Mark D., Izes, Joseph, Karnes, R. Jeffrey, Lallas, Costas, Languino, Lucia, Loeb, Stacy, Lopez, Ana Maria, Loughlin, Kevin R., Lu-Yao, Grace, Malkowicz, S. Bruce, Mann, Mark, Mille, Patrick, Miner, Martin M., Morgan, Todd, Moreno, Jose, Mucci, Lorelei, Myers, Ronald E., Nielsen, Sarah M., O’Neil, Brock, Pinover, Wayne, Pinto, Peter, Poage, Wendy, Raj, Ganesh V., Rebbeck, Timothy R., Ryan, Charles, Sandler, Howard, Schiewer, Matthew, Scott, E. Michael D., Szymaniak, Brittany, Tester, William, Trabulsi, Edouard J., Vapiwala, Neha, Yu, Evan Y., Zeigler-Johnson, Charnita, Gomella, Leonard G. · 2020 · Journal of Clinical Oncology

Abstract

PURPOSE: Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in GT indications and management, and alternate genetic evaluation models that address the rising demand for genetic services. METHODS: A multidisciplinary consensus conference that included experts, stakeholders, and national organization leaders was convened in response to current practice challenges and to develop a genetic implementation framework. Evidence review informed questions using the modified Delphi model. The final framework included criteria with strong (> 75%) agreement (Recommend) or moderate (50% to 74%) agreement (Consider). RESULTS: Large germline panels and somatic testing were recommended for metastatic PCA. Reflex testing—initial testing of priority genes followed by expanded testing—was suggested for multiple scenarios. Metastatic disease or family history suggestive of hereditary PCA was recommended for GT. Additional family history and pathologic criteria garnered moderate consensus. Priority genes to test for metastatic disease treatment included BRCA2, BRCA1, and mismatch repair genes, with broader testing, such as ATM, for clinical trial eligibility. BRCA2 was recommended for active surveillance discussions. Screening starting at age 40 years or 10 years before the youngest PCA diagnosis in a family was recommended for BRCA2 carriers, with consideration in HOXB13, BRCA1, ATM, and mismatch repair carriers. Collaborative (point-of-care) evaluation models between health care and genetic providers was endorsed to address the genetic counseling shortage. The genetic evaluation framework included optimal pretest informed consent, post-test discussion, cascade testing, and technology-based approaches. CONCLUSION: This multidisciplinary, consensus-driven PCA genetic implementation framework provides novel guidance to clinicians and patients tailored to the precision era. Multiple research, education, and policy needs remain of importance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.20.00046

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 275

Metadata

Authors
Giri, V. N., Knudsen, K. E., Kelly, W. K., Cheng, H. H., Cooney, K. A., Cookson, M. S., Dahut, W., Weissman, S., Soule, H. R., Petrylak, D. P., Dicker, A. P., AlDubayan, S. H., Toland, A. E., Pritchard, C. C., Pettaway, C. A., Daly, M. B., Mohler, J. L., Parsons, J. K., Carroll, P. R., Pilarski, R., Blanco, A., Woodson, A., Rahm, A., Taplin, M.-E., Polascik, T. J., Helfand, B. T., Hyatt, C., Morgans, A. K., Feng, F., Mullane, M., Powers, J., Concepcion, R., Lin, D. W., Wender, R., Mark, J. R., Costello, A., Burnett, A. L., Sartor, O., Isaacs, W. B., Xu, J., Weitzel, J., Andriole, G. L., Beltran, H., Briganti, A., Byrne, L., Calvaresi, A., Chandrasekar, T., Chen, D. Y. T., Den, R. B., Dobi, A., Crawford, E. D., Eastham, J., Eggener, S., Freedman, M. L., Garnick, M., Gomella, P. T., Handley, N., Hurwitz, M. D., Izes, J., Karnes, R. J., Lallas, C., Languino, L., Loeb, S., Lopez, A. M., Loughlin, K. R., Lu-Yao, G., Malkowicz, S. B., Mann, M., Mille, P., Miner, M. M., Morgan, T., Moreno, J., Mucci, L., Myers, R. E., Nielsen, S. M., O’Neil, B., Pinover, W., Pinto, P., Poage, W., Raj, G. V., Rebbeck, T. R., Ryan, C., Sandler, H., Schiewer, M., Scott, E. M. D., Szymaniak, B., Tester, W., Trabulsi, E. J., Vapiwala, N., Yu, E. Y., Zeigler-Johnson, C., & Gomella, L. G.
Venue
Journal of Clinical Oncology
Published
2020-08-20
Volume
38
Issue
24
Pages
2798-2811
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W3033920919
Cited by
275
References
76
FWCI
23.94
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. https://app.cochat.ai/papers/10.1200/jco.20.00046
The paper
Giri, V. N., Knudsen, K. E., Kelly, W. K., Cheng, H. H., Cooney, K. A., Cookson, M. S., Dahut, W., Weissman, S., Soule, H. R., Petrylak, D. P., Dicker, A. P., AlDubayan, S. H., Toland, A. E., Pritchard, C. C., Pettaway, C. A., Daly, M. B., Mohler, J. L., Parsons, J. K., Carroll, P. R., . . . Gomella, L. G. (2020). Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. Journal of Clinical Oncology. https://doi.org/10.1200/jco.20.00046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.